Evaluation of an initiative to address polypharmacy in hospitalized older adults

Author:

Meaney Calvin J.1ORCID,Tjota Natalie2,Pham Kevin3,Prescott Gina1ORCID,Doloresco Fred1,Ott Michael4,Wahler Robert3ORCID,Wikerd Zachary2

Affiliation:

1. University at Buffalo School of Pharmacy and Pharmaceutical Sciences, Erie County Medical Center Buffalo New York USA

2. University at Buffalo Jacobs School of Medicine and Biomedical Sciences Erie County Medical Center Buffalo New York USA

3. University at Buffalo School of Pharmacy and Pharmaceutical Sciences Buffalo New York USA

4. Erie County Medical Center Buffalo New York USA

Abstract

AbstractBackgroundPolypharmacy contributes to medication‐related harm in older adults. Deprescribing interventions are often employed in the outpatient setting, potentially missing patients with limited healthcare access. Hospitalization represents a unique touch point to address polypharmacy in older adults with a multidisciplinary team.MethodsThis retrospective cohort study examined the feasibility and effectiveness of a polypharmacy intervention in hospitalized older adults. The intervention was developed by a multidisciplinary team with a quality improvement framework and implemented by clinical pharmacists on an academic teaching service. Adults aged 65 years and older were included. Pharmacists completed a comprehensive medication review with the identification of medication therapy problems (MTPs), with additional evaluation for polypharmacy (five or more chronic medications) and potentially inappropriate medications (PIMs) using validated tools (Beers and STOPP/START criteria), with recommendations implemented during hospitalization. Descriptive statistics were used to describe the intervention and its outcomes. Reporting followed the SQUIRE statement.ResultsThe polypharmacy intervention was provided to 155 patients. Polypharmacy occurred in 98.7% of older adults, whereas 82.6% received at least one PIM (261 total). This demonstrates a significant need for an intervention to address polypharmacy and PIMs during hospitalization. A median of two MTPs was identified per patient (total 287), the most common being adverse drug reaction (present in 52.3% of patients), medication without indication (47.7%), and indication without medication (31%). Opioids were the most common PIM (present in 36.1% of patients), followed by benzodiazepines (10.3%) and skeletal muscle relaxants (8.4%). A total of 40.6% of PIMs were successfully deprescribed at discharge.ConclusionPolypharmacy is ubiquitous in hospitalized older adults. A multidisciplinary approach to deprescribing can reduce PIMs during hospitalization.

Publisher

Wiley

Reference31 articles.

1. Polypharmacy: evaluating risks and Deprescribing;Halli‐Tierney AD;Am Fam Physician,2019

2. Prevalence and trends of polypharmacy in U.S. adults, 1999‐2018. Glob Health;Wang X;Res Policy,2023

3. Medication Safety in Polypharmacy.Geneva: World Health Organization; 2019 (WHO/UHC/SDS/2019.11). Licence: CC BY‐NC‐SA 3.0 IGO. Available from:https://iris.who.int/bitstream/handle/10665/325454/WHO-UHC-SDS-2019.11-eng.pdf?sequence=1. Accessed 14 Jan 2024.

4. Deprescribing interventions and their impact on medication adherence in community-dwelling older adults with polypharmacy: a systematic review

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3